APYX
APYX
NASDAQ · Health Care

Apyx Medical Corp

$4.05
-0.31 (-7.11%)
Financial Highlights (FY 2026)
Revenue
56.79M
Net Income
-12,047,921
Gross Margin
62.5%
Profit Margin
-21.2%
Rev Growth
+5.9%
D/E Ratio
2.40
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.5% 62.5% 36.7% 36.7%
Operating Margin -12.2% -11.0% 18.0% 17.4%
Profit Margin -21.2% -20.2% 11.0% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 56.79M 53.63M 88.82M 91.82M
Gross Profit 35.51M 33.54M 32.57M 33.67M
Operating Income -6,928,429 -5,888,739 16.01M 15.98M
Net Income -12,047,921 -10,239,993 9.74M 12.10M
Gross Margin 62.5% 62.5% 36.7% 36.7%
Operating Margin -12.2% -11.0% 18.0% 17.4%
Profit Margin -21.2% -20.2% 11.0% 13.2%
Rev Growth +5.9% +5.9% -9.1% +17.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 59.85M 59.85M 11.75M 11.58M
Total Equity 24.95M 24.95M 90.85M 91.27M
D/E Ratio 2.40 2.40 0.13 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -6,125,537 -5,495,571 18.03M 21.54M
Free Cash Flow 4.63M 6.18M